The Third Of Three Pivotal Head-To-Head Trials Submitted To FDA For Treatment Of Patients With Bone MetastasesCONTACT: Amgen, Thousand Oaks Lisa Rooney: + 1 (805) 559-0739 (media) Arvind Sood: +1 (805) 447-1060 (investors)
